Evidence map›Paper›PMID 20186301›Full record

ArticleClinics (Sao Paulo, Brazil)2010

Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients.

Fazile Hatipoglu Erdem, Saliha Karatay, Kadir Yildirim, Ahmet Kiziltunc

Open access · goldAbstract read
In one paragraph

Article in Clinics (Sao Paulo, Brazil), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Food science & nutrition · 2021
    Article
  3. Article
  4. Article
  5. Serum paraoxonase and arylesterase activities in patients with chronic otitis media.Redox report : communications in free radical research · 2015
    Article
  6. Article
  7. Vitamin D status in patients with Behcet's Disease.Clinics (Sao Paulo, Brazil) · 2011
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Fazile Hatipoglu ErdemDepartment of Physical Medicine and Rehabilitation, Sifa Hospital - Erzurum, Turkey. fazilehe@hotmail.com
Saliha Karatay
Kadir Yildirim
Ahmet Kiziltunc
Atatürk University · TRŞifa University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe aim of this study was to investigate the activities of serum paraoxonase and arylesterase in patients with ankylosing spondylitis with respect to those of healthy controls, to assess whether these enzyme levels are related to disease activity and functional capacity.

methodsThe study included 32 patients with ankylosing spondylitis whose diagnoses were made according to the modified New York criteria as well as 25 healthy controls matched for age and sex. The Bath Ankylosing Spondylitis Disease Activity Index and the Bath Ankylosing Spondylitis Functional Index were applied to the ankylosing spondylitis patients. As laboratory parameters, the erythrocyte sedimentation rate and serum C-reactive protein level were measured in patients and control subjects. Paraoxonase and arylesterase enzyme activities were measured using appropriate methods.

resultsNo statistically significant differences (p>0.05) were found between the ankylosing spondylitis patients and controls in terms of serum paraoxonase or arylesterase levels. Furthermore, there was no correlation between clinical and laboratory parameters in patients with ankylosing spondylitis.

conclusionSerum paraoxonase and arylesterase levels in ankylosing spondylitis patients may not differ from those of healthy controls, and there is no significant correlation between antioxidant parameters and the Bath Ankylosing Spondylitis Disease Activity Index or Bath Ankylosing Spondylitis Functional Index scores in ankylosing spondylitis patients. Further research is needed to provide deeper understanding of this disease.

Indexed as

AdultAgedAryldialkylphosphataseBiomarkersBlood SedimentationCarboxylic Ester HydrolasesCase-Control StudiesC-Reactive ProteinFemaleHumansMaleMiddle AgedSeverity of Illness IndexSpondylitis, AnkylosingYoung AdultAryldialkylphosphatasearylesteraseBiomarkersCarboxylic Ester HydrolasesC-Reactive ProteinAnkylosing SpondylitisAntioxidant enzymesArylesteraseOxidative stressParaoxonase

Identifiers

PMID20186301
PMCPMC2827704
OpenAlexW2144469326

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.